BRCA2 and ovarian cancer: The lifetime risk of spontaneously developing and dying from ovarian cancer are 1.39 and 1.04%, respectively; however, the incidence of developing ovarian cancer significantly increases in carriers of germline mutations, mainly with either the breast cancer gene 1 (BRCA1) or 2 (BRCA2) genes.